Health care resource utilization with asciminib and bosutinib among adults with chronic myeloid leukemia in chronic phase previously treated with ≥2 tyrosine kinase inhibitors: Week 48 and week 96 results from ASCEMBL trial Meeting Abstract
| Authors: | Cortes, J. E.; Sasaki, K.; Réa, D.; Mauro, M. J.; Tran, D.; Wang, P.; Jadhav, K.; Di Caprio, L.; Yocolly, A. |
| Abstract Title: | Health care resource utilization with asciminib and bosutinib among adults with chronic myeloid leukemia in chronic phase previously treated with ≥2 tyrosine kinase inhibitors: Week 48 and week 96 results from ASCEMBL trial |
| Meeting Title: | ISPOR Europe 2022 |
| Journal Title: | Value in Health |
| Volume: | 25 |
| Issue: | 12 Suppl. |
| Meeting Dates: | 2022 Nov 6-9 |
| Meeting Location: | Vienna, Italy |
| ISSN: | 1098-3015 |
| Publisher: | Elsevier Science, Inc. |
| Date Published: | 2022-12-01 |
| Start Page: | S125 |
| End Page: | S126 |
| Language: | English |
| ACCESSION: | WOS:000897594900559 |
| PROVIDER: | wos |
| DOI: | 10.1016/j.jval.2022.09.606 |
| Notes: | Meeting Abstract: EE360 -- Source: Wos |
